Nantahala Capital Management, LLC Amylyx Pharmaceuticals, Inc. Put Options Transaction History
Nantahala Capital Management, LLC
- $2.22 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding AMLX
# of Institutions
148Shares Held
73MCall Options Held
148KPut Options Held
98.7K-
Perceptive Advisors LLC New York, NY7.87MShares$38.6 Million1.17% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA5.94MShares$29.1 Million5.07% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.7MShares$27.9 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.12MShares$20.2 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.08MShares$15.1 Million0.01% of portfolio
About Amylyx Pharmaceuticals, Inc.
- Ticker AMLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,533,200
- Market Cap $287M
- Description
- Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...